Back to Top

For Authors

Biotechnology Law Report invites the submission of original manuscripts covering all aspects of biotechnology law. Send manuscripts to Managing Editor Steven J. Zweig. Please see email directly below.

Paper Submission
Articles should be submitted in electronic form, as e-mail attachments to

Please specify in the text of the e-mail the word processing format used in creating the manuscript.  Microsoft Word is preferred.

Use of English Language
All submissions must be in English. Appropriate use of English is a requirement for review and publication in Biotechnology Law Report. To support non-native speakers, Mary Ann Liebert, Inc., has partnered with Editage to provide language editing and translation services for a fee prior to official submission. To learn more about the services, please visit the Liebert Author Services website. Please note that employing the use of such services is not mandatory and using it, or any other language editing service, does not guarantee the acceptance of any paper. All submissions are subject to peer review.

SPECIAL OPEN ACCESS publishing option -- Contact:

Using Blue Book format, please generate footnotes cited by superscript reference numerals throughout the text.  We reserve the right to modify style to conform to the Journal’s overall style.  Suggested readings or lists of other source materials may also be included in a final footnote.

The author must obtain permission to reproduce from any copyrighted material. Written permission must be obtained from the original copyright holder (generally the publisher) of the journal or book concerned. An appropriate credit line and copyright notice should be included and a full citation should be included in the reference list.

Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.

Biotechnology Law Report is published six times a year by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215.  Telephone: (914) 740–2100; fax: (914) 740–2101.

Millions of papers are published every year. Make yours stand out.

The things that matter to you are the things that matter to us: speed, quality, access, and exposure. We work hand-in-hand with you to rapidly prepare, submit, publish, and disseminate your research to ensure it receives the attention and long-term impact it deserves.

Our unique publishing experience delivers:
  • One-on-one expert guidance and communication, from pre-submission inquiries through to post-publication marketing
  • Prompt first editorial decision, with referral options available to other leading journals in our portfolio
  • Rigorous peer review and editorial oversight from leading specialists in your field
  • Zero-embargo green Open Access policy ensures that you comply with funder mandates; you have the option to post the accepted version of your manuscript to your institutional repository or personal website immediately upon publication of the Version of Record
  • Rapid online-first publication ensures your work is available to read, cite, and make an impact as soon as possible
  • All article pages are search engine optimized (SEO) using the latest technologies, making it easy for readers to find and access your work through online searches
  • Immediate deposit of your work to highly visible indexing services upon publication, maximizing your discoverability across all major research platforms
  • Free 30-day access to your published research to share your work among colleagues, social networks, and with anyone who may be interested in your work
  • Availability in library and institutional resource collections in more than 170 countries as well as through Research4Life, which makes your research freely available in developing countries
  • Opportunity for your work to be featured in our highly successful marketing and public relations campaigns that amplify your impact


Mary Ann Liebert, Inc. has partnered with Editage and Impact Science to provide you with an additional dynamic suite of specialized editorial services to ensure your manuscript has the impact it deserves. Learn more about how we can take your paper to the next level with our pre-submission English Language Editing and English-Language Translation with Editing Services, as well as our post-publication Research Promotion Services – including infographics, video abstracts, plain language summaries, and more.

Visit our Author Services portal now for more information and to get started!


All Editage services are fee-based services that authors can opt-into as an added author benefit to amplify the readability, visibility, findability, and shareability of their work.

Publishing Open Access

Open Access enables you to publish your work under a Creative Commons (CC-BY) copyright license in our esteemed hybrid journals. Publishing Open Access makes your article immediately available to read globally, increasing the visibility and potential impact of your research.

Benefits of Publishing Open Access:
  • Maximum visibility: open access articles are freely available online upon publication with no subscription needed
  • Authors retain copyright, allowing broad dissemination of research
  • Articles can be freely shared in repositories and research networks without restrictions
  • Automatic submission to PubMed Central and PMC mirror sites, when applicable*
  • Open access articles are listed with an OA icon in journal tables of content (TOC), TOC email alerts, and in marketing announcements
Choosing Open Access

Once your article has been accepted for publication, you will receive an email with information on how to order open access. An Article Processing Charge (APC) is required to cover the cost of Open Access publication and article processing. Once payment is received your article will be published Open Access.

Copyright and Licensing

Under Open Access, authors retain copyright via a Creative Commons license. Authors may choose between the Creative Commons (CC BY) license and CC BY-Noncommercial (CC BY-NC) license.

  • The CC BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
  • The CC BY-NC license permits any noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.

*Please note that PubMed Central, not the Publisher, has sole control over when the paper is made live on PMC.

You can find out more about additional publication services, browse our portfolio of fully open access journals, read FAQs, and more on our Liebert Open Access page or by contacting

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.